RUA.L

RUA Life Sciences plc [RUA.L] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

RUA.L Stock Summary

Top 10 Correlated ETFs

RUA.L

Top 10 Correlated Stocks

RUA.L

In the News

RUA.L Financial details

Company Rating
-
Market Cap
7.45M
Income
-3.77M
Revenue
3.89M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
48
Optionable
No
Shortable
Yes
Earnings
17 Jul 2024
P/E
-1.86
Forward P/E
-
PEG
-0.23
P/S
5.04
P/B
0.57
P/C
-
P/FCF
-6.22
Quick Ratio
3.58
Current Ratio
5.2
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.17
EPS next Y
-
EPS next Q
-
EPS this Y
-3.11%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
13.85%
Revenue last 5Y
36.31%
Revenue Q/Q
-26.14%
EPS Q/Q
17.27%
-
-
-
-
SMA20
-
SMA50
-7.69%
SMA100
9.09%
Inst Own
-
Inst Trans
-
ROA
-25%
ROE
59%
ROC
-0.33%
Gross Margin
79%
Oper. Margin
-107%
Profit Margin
-88%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
8.5-58.75
52W High
-79.96%
52W Low
+45.31%
RSI
49
Rel Volume
0.09
Avg Volume
731.67K
Volume
65.77K
Perf Week
1.09%
Perf Month
-5.1%
Perf Quarter
1.09%
Perf Half Y
-7%
-
-
-
-
Beta
1.276
-
-
Volatility
0.27%, 0.41%
Prev Close
-0.04%
Price
11.625
Change
2.69%

Something similar

Top by Market Cap
FXAIX
M&M.NS
GOOG
0YXG.L
TL0.DE
Top Correlated ETFs
SC00.DE
ELFC.DE
EGRA.MI
HEDK.L
XDUD.SW
Top Correlated Stocks
NESTE.HE
ENG.WA
0K9W.IL
0GWB.IL
UNIBAP.ST
Similar Market Cap
CREG
RDHL
ASND.TO
PCSA
CHIR

Company Profile

Healthcare Medical - Devices
  • Volume Average 731.67K
  • Market Capitalization 7.45M
  • Employee 48
  • CEO Mr. William Donald Brown
  • Headquarters Irvine,GB
  • IPO Date 1997-02-26
  • Website https://rualifesciences.com

RUA Life Sciences plc, together with its subsidiaries, provides polymers, services, and products to the medical device industry in Europe, the United States, and internationally. The company operates as a contract developer and manufacturer of medical devices; and licensor of Elast-Eon and ECSil implantable co-polymers that are used in cardiology and urological applications, including pacing leads, cardiac cannulae, and stent devices, as well as reaction injection molding technology for use in high-precision medical device components. It also develops bore polymer sealed grafts and soft tissue patches; and tri leaflet polymeric heart valves. The company was formerly known as AorTech International plc and changed its name to RUA Life Sciences plc in June 2020. RUA Life Sciences plc was incorporated in 1996 and is headquartered in Irvine, the United Kingdom.